Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Non-Current Deffered Revenue (2024 - 2025)

Volitionrx (VNRX) has disclosed Non-Current Deffered Revenue for 2 consecutive years, with $22.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Deffered Revenue changed N/A year-over-year to $22.0 million, compared with a TTM value of $22.0 million through Sep 2025, changed N/A, and an annual FY2024 reading of $22.7 million, changed N/A over the prior year.
  • Non-Current Deffered Revenue was $22.0 million for Q3 2025 at Volitionrx, down from $22.7 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $22.7 million in Q4 2024 and bottomed at $22.0 million in Q3 2025.